166 related articles for article (PubMed ID: 19841179)
1. A NUP98-HOXD13 fusion gene impairs differentiation of B and T lymphocytes and leads to expansion of thymocytes with partial TCRB gene rearrangement.
Choi CW; Chung YJ; Slape C; Aplan PD
J Immunol; 2009 Nov; 183(10):6227-35. PubMed ID: 19841179
[TBL] [Abstract][Full Text] [Related]
2. Depletion of cytotoxic T-cells does not protect NUP98-HOXD13 mice from myelodysplastic syndrome but reveals a modest tumor immunosurveillance effect.
Gough SM; Chung YJ; Aplan PD
PLoS One; 2012; 7(5):e36876. PubMed ID: 22606303
[TBL] [Abstract][Full Text] [Related]
3. NUP98-HOX translocations lead to myelodysplastic syndrome in mice and men.
Slape C; Lin YW; Hartung H; Zhang Z; Wolff L; Aplan PD
J Natl Cancer Inst Monogr; 2008; (39):64-8. PubMed ID: 18648006
[TBL] [Abstract][Full Text] [Related]
4. Retroviral insertional mutagenesis identifies genes that collaborate with NUP98-HOXD13 during leukemic transformation.
Slape C; Hartung H; Lin YW; Bies J; Wolff L; Aplan PD
Cancer Res; 2007 Jun; 67(11):5148-55. PubMed ID: 17545593
[TBL] [Abstract][Full Text] [Related]
5. A NUP98-HOXD13 leukemic fusion gene leads to impaired class switch recombination and antibody production.
Puthiyaveetil AG; Heid B; Reilly CM; HogenEsch H; Caudell DL
Exp Hematol; 2012 Aug; 40(8):622-33. PubMed ID: 22613470
[TBL] [Abstract][Full Text] [Related]
6. Promoter activity 5' of Dbeta2 is coordinated by E47, Runx1, and GATA-3.
McMillan RE; Sikes ML
Mol Immunol; 2009 Sep; 46(15):3009-17. PubMed ID: 19592096
[TBL] [Abstract][Full Text] [Related]
7. The requirement for pre-TCR during thymic differentiation enforces a developmental pause that is essential for V-DJβ rearrangement.
Hathcock KS; Farrington L; Ivanova I; Livak F; Selimyan R; Sen R; Williams J; Tai X; Hodes RJ
PLoS One; 2011; 6(6):e20639. PubMed ID: 21673984
[TBL] [Abstract][Full Text] [Related]
8. Beta-selection: abundance of TCRbeta-/gammadelta- CD44- CD25- (DN4) cells in the foetal thymus.
Hager-Theodorides AL; Rowbotham NJ; Outram SV; Dessens JT; Crompton T
Eur J Immunol; 2007 Feb; 37(2):487-500. PubMed ID: 17273993
[TBL] [Abstract][Full Text] [Related]
9. Non-homologous end joining mediated DNA repair is impaired in the NUP98-HOXD13 mouse model for myelodysplastic syndrome.
Puthiyaveetil AG; Reilly CM; Pardee TS; Caudell DL
Leuk Res; 2013 Jan; 37(1):112-6. PubMed ID: 23131583
[TBL] [Abstract][Full Text] [Related]
10. A role for MAPK in feedback inhibition of Tcrb recombination.
Jackson AM; Krangel MS
J Immunol; 2006 Jun; 176(11):6824-30. PubMed ID: 16709842
[TBL] [Abstract][Full Text] [Related]
11. Brief report: Loss of p15Ink4b accelerates development of myeloid neoplasms in Nup98-HoxD13 transgenic mice.
Humeniuk R; Koller R; Bies J; Aplan P; Wolff L
Stem Cells; 2014 May; 32(5):1361-6. PubMed ID: 24449168
[TBL] [Abstract][Full Text] [Related]
12. Expression of TCR alpha beta partly rescues developmental arrest and apoptosis of alpha beta T cells in Bcl11b-/- mice.
Inoue J; Kanefuji T; Okazuka K; Watanabe H; Mishima Y; Kominami R
J Immunol; 2006 May; 176(10):5871-9. PubMed ID: 16670294
[TBL] [Abstract][Full Text] [Related]
13. Fc gamma RII/III and CD2 expression mark distinct subpopulations of immature CD4-CD8- murine thymocytes: in vivo developmental kinetics and T cell receptor beta chain rearrangement status.
Rodewald HR; Awad K; Moingeon P; D'Adamio L; Rabinowitz D; Shinkai Y; Alt FW; Reinherz EL
J Exp Med; 1993 Apr; 177(4):1079-92. PubMed ID: 8096236
[TBL] [Abstract][Full Text] [Related]
14. The Ets-1 transcription factor is required for complete pre-T cell receptor function and allelic exclusion at the T cell receptor beta locus.
Eyquem S; Chemin K; Fasseu M; Bories JC
Proc Natl Acad Sci U S A; 2004 Nov; 101(44):15712-7. PubMed ID: 15496469
[TBL] [Abstract][Full Text] [Related]
15. Biased V beta usage in immature thymocytes is independent of DJ beta proximity and pT alpha pairing.
Wilson A; Maréchal C; MacDonald HR
J Immunol; 2001 Jan; 166(1):51-7. PubMed ID: 11123276
[TBL] [Abstract][Full Text] [Related]
16. Early onset of CD8 transgene expression inhibits the transition from DN3 to DP thymocytes.
Wack A; Coles M; Norton T; Hostert A; Kioussis D
J Immunol; 2000 Aug; 165(3):1236-42. PubMed ID: 10903721
[TBL] [Abstract][Full Text] [Related]
17. NUP98-HOXA9 bearing therapy-related myeloid neoplasm involves myeloid-committed cell and induces HOXA5, EVI1, FLT3, and MEIS1 expression.
Burillo-Sanz S; Morales-Camacho RM; Caballero-Velázquez T; Vargas MT; García-Lozano JR; Falantes JF; Prats-Martín C; Bernal R; Pérez-Simón JA
Int J Lab Hematol; 2016 Feb; 38(1):64-71. PubMed ID: 26418229
[TBL] [Abstract][Full Text] [Related]
18. A novel role for HEB downstream or parallel to the pre-TCR signaling pathway during alpha beta thymopoiesis.
Barndt R; Dai MF; Zhuang Y
J Immunol; 1999 Sep; 163(6):3331-43. PubMed ID: 10477603
[TBL] [Abstract][Full Text] [Related]
19. Differential and common leukemogenic potentials of multiple NUP98-Hox fusion proteins alone or with Meis1.
Pineault N; Abramovich C; Ohta H; Humphries RK
Mol Cell Biol; 2004 Mar; 24(5):1907-17. PubMed ID: 14966272
[TBL] [Abstract][Full Text] [Related]
20. Mouse embryonic stem cells that express a NUP98-HOXD13 fusion protein are impaired in their ability to differentiate and can be complemented by BCR-ABL.
Slape C; Chung YJ; Soloway PD; Tessarollo L; Aplan PD
Leukemia; 2007 Jun; 21(6):1239-48. PubMed ID: 17377591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
